scholarly journals Economic Impact and Cost Benefit of the Inpatient Clinical Pharmacist Interventions in Cancer Care Units

2022 ◽  
Author(s):  
Dina Abushanab ◽  
Amaal Gulied ◽  
Anas Hamad ◽  
Palli Valappila Abdul Rouf ◽  
Moza Al Hail ◽  
...  
Keyword(s):  
Clinical Pharmacist ◽  
Cancer Care ◽  
Cost Benefit Analysis ◽  
Cost Savings ◽  
Cost Benefit ◽  
Therapeutic Interventions ◽  
Cost Ratio ◽  
Benefit Analysis ◽  
Net Benefit ◽  
The Cost

Abstract Background: Clinical pharmacists play a key role in ensuring the optimum use of cancer medicines. Yet, the economic benefit of this role has never been assessed in Qatar. Aim: To evaluate the overall economic impact of clinical pharmacist interventions in the main cancer care setting in Qatar. Methods: From the public healthcare perspective, this was an analysis of the total economic benefit and a cost-benefit analysis of the clinical pharmacy interventions. As a study sample size, patient records in March 2018, July/August 2018, and January 2019 were retrospectively reviewed at the National Center for Cancer Care & Research (NCCCR), Qatar. The total benefit from interventions was the total of the cost avoidance due to preventable adverse drug events (ADEs) plus the cost savings associated with therapeutic interventions. The interventions cost was based on salary and increased cost due to therapeutic interventions. The cost-benefit analysis results were presented via net benefit and benefit‐to‐cost ratio measures. Results : Total of 1,352 interventions occurred during the 3-month follow-up period. The total benefit was QAR 196,010,360 (USD53,834,206), constituting cost avoidance of QAR 194,764,534 (USD 53,492,040) and cost savings of QAR 1,245,826 (USD 342,166), mostly due to recommending additional medications and the medication dose reduction. The benefit-to-cost ratio was 174:1 and the annual net benefit was QAR 779,539,440 (USD 214,100,351). Sensitivity analyses confirmed the robustness of results. Conclusion: The clinical pharmacist intervention is a cost-beneficial practice in the NCCCR setting, associated with ADEs prevention and substantial economic benefits, including relative to the interventions cost.

scholarly journals Economic Analysis of the Use of VCS2000 for Pork Carcass Meat Yield Grading in Korea

Animals ◽  
2021 ◽  
Vol 11 (5) ◽  
pp. 1297
Author(s):  
Juntae Kim ◽  
Hyo-Dong Han ◽  
Wang Yeol Lee ◽  
Collins Wakholi ◽  
Jayoung Lee ◽  
...  
Keyword(s):  
Economic Analysis ◽  
Net Present Value ◽  
Cost Benefit Analysis ◽  
Cost Benefit ◽  
Feed Consumption ◽  
Cost Ratio ◽  
Benefit Analysis ◽  
Labor Costs ◽  
Meat Yield ◽  
The Cost

Currently, the pork industry is incorporating in-line automation with the aim of increasing the slaughtered pork carcass throughput while monitoring quality and safety. In Korea, 21 parameters (such as back-fat thickness and carcass weight) are used for quality grading of pork carcasses. Recently, the VCS2000 system—an automatic meat yield grading machine system—was introduced to enhance grading efficiency and therefore increase pork carcass production. The VCS2000 system is able to predict pork carcass yield based on image analysis. This study also conducted an economic analysis of the system using a cost—benefit analysis. The subsection items of the cost-benefit analysis considered were net present value (NPV), internal rate of return (IRR), and benefit/cost ratio (BC ratio), and each method was verified through sensitivity analysis. For our analysis, the benefits were grouped into three categories: the benefits of reducing labor costs, the benefits of improving meat yield production, and the benefits of reducing pig feed consumption through optimization. The cost-benefit analysis of the system resulted in an NPV of approximately 615.6 million Korean won, an IRR of 13.52%, and a B/C ratio of 1.65.

scholarly journals Cost-benefit analysis of pharmacist interventions over 36 months in a university hospital

2020 ◽  
Vol 54 ◽  
pp. 94
Author(s):  
Maurilio de Souza Cazarim ◽  
João Paulo Vilela Rodrigues ◽  
Priscila Santos Calcini ◽  
Thomas Einarson ◽  
Leonardo Régis Leira Pereira
Keyword(s):  
Marginal Cost ◽  
Cost Benefit Analysis ◽  
Cost Benefit ◽  
University Hospital ◽  
Cost Ratio ◽  
Benefit Analysis ◽  
Net Benefit ◽  
Hospital Perspective ◽  
Benefit Cost Ratio ◽  
Tertiary Teaching

OBJECTIVE: To perform a cost-benefits analysis of a clinical pharmacy (CP) service implemented in a Neurology ward of a tertiary teaching hospital. METHODS: This is a cost-benefit analysis of a single arm, prospective cohort study performed at the adult Neurology Unit over 36 months, which has evaluated the results of a CP service from a hospital and Public Health System (PHS) perspective. The interventions were classified into 14 categories and the costs identified as direct medical costs. The results were analyzed by the total and marginal cost, the benefit-cost ratio (BCR) and the net benefit (NB). RESULTS: The total 334 patients were followed-up and the highest occurrence in 506 interventions was drug introduction (29.0%). The marginal cost for the hospital and avoided cost for PHS was US$182±32 and US$25,536±4,923 per year; and US$0.55 and US$76.4 per patient/year. The BCR and NB were 0.0, -US$26,105 (95%CI -31,850 – -10,610), -US$27,112 (95%CI -33,160–11,720) for the hospital and; 3.0 (95%CI 1.97–4.94), US$51,048 (95%CI 27,645–75,716) and, 4.6 (95%CI 2.24–10.05), US$91,496 (95%CI 34,700–168,050; p < 0.001) for the PHS, both considering adhered and total interventions, respectively. CONCLUSIONS: The CP service was not directly cost-benefit at the hospital perspective, but it presented savings for forecast cost related to the occurrence of preventable morbidities, measuring a good cost-benefit for the PHS.

scholarly journals Guide to cost benefit analysis of community-based interventions

2014 ◽  
Vol 3 (5) ◽  
pp. 47
Author(s):  
Sanni Yaya ◽  
Xiaonan Li
Keyword(s):  
Net Present Value ◽  
Cost Benefit Analysis ◽  
Cost Benefit ◽  
Cost Ratio ◽  
Benefit Analysis ◽  
Costs And Benefits ◽  
Community Based Interventions ◽  
Community Based ◽  
Benefit Cost Ratio ◽  
The Cost

This paper offers a general guide on how to conduct a proper economic analysis for community-based intervention projects. Identification and quantification of costs and benefits are the focus of the cost benefit analysis. We categorize costs and benefits from human and physical perspectives and pay special attention to the measures of saving human lives accompanied by the proposed calculation methods. We recommend net present value and benefit-cost ratio as the criteria to assess projects and highlight some challenges remaining in the analysis.

scholarly journals Cost-benefit Analysis of Seedling Production on Floating Beds in a Few Selected Areas of Bangladesh

2019 ◽  
Vol 7 (2) ◽  
pp. 75
Author(s):  
Mohammod Akbar Kabir ◽  
Md. Moniruzzaman ◽  
Kawsar Jahan ◽  
Md. Shahjahan
Keyword(s):  
Cost Benefit Analysis ◽  
Cost Benefit ◽  
Sampling Technique ◽  
Primary Data ◽  
Seedling Production ◽  
Benefit Analysis ◽  
Net Benefit ◽  
Government Aid ◽  
Combat Climate Change ◽  
The Cost

The aim of this study was to calculate the cost benefit analysis and economic viability of seedling production on the floating bed at Nazirpur Upazila in Pirojpur district of Bangladesh. The study area was selected purposively and 50 households (HHs) were surveyed through purposive sampling technique from a population of 80 households. From the results of those primary data, it was found that 68% farmers were engaged in seedling production as business purpose, and 30% as both own and business, 21 vegetables and spices seedlings were cultivated in the studied area. Average per square meter cost for floating seedling cultivation found BDT (Bangladeshi taka) 281 and benefit was BDT 401. The net benefit of floating agriculture found BDT 120 and with a BCR of 1.43. Income from floating seedlings mainly utilized in winter vegetable cultivation (Kandi), mainstream agriculture, business, house development and land purchase etc. Fifty percent (50%) of the floating farmers mentioned various constraints regarding floating seedling production such as lack of government aid, higher interest from NGOs and lack of capital. Among the surveyed respondents, 64% agreed that floating cultivation is effective to combat climate change and 76% replied as beneficial to the environment. Although floating agriculture is an indigenous age-old practice in the South-western region of Bangladesh, it can be replicated with the help of subsidy and agro-technology.

Environmental costs and their impact on the net present value of a hydro-electric project in Kerala, India

2003 ◽  
Vol 8 (2) ◽  
pp. 311-330 ◽  
Author(s):  
V. Santhakumar ◽  
Achin Chakraborty
Keyword(s):  
Net Present Value ◽  
Cost Benefit Analysis ◽  
Cost Benefit ◽  
Environmental Costs ◽  
Benefit Analysis ◽  
Costs And Benefits ◽  
Net Benefit ◽  
Pulp Industry ◽  
The Social ◽  
The Cost

This paper presents the operational procedures involved in incorporating the environmental costs in the cost–benefit analysis of a hydro-electric project. The proposed project, if implemented, would result in the loss of 2,800 hectares of tropical forests and dislocation of two settlements of about 200 families who are currently dependent on the forests for their livelihood. The forests are mainly used for extracting reed – a material used both by traditional artisans and the paper-pulp industry. The potential environmental costs and benefits of the project are identified and approximate estimates of some of these costs are made for items such as carbon sequestration, bio-diversity, and so on, based on similar estimates made elsewhere. These estimated environmental costs are incorporated into the analysis, and the hypothetical estimate of the non-use value, which would make the project's net benefit zero, is estimated under different discount rates. The analysis brings into sharp focus some crucial factors that have a direct bearing on the social trade-off involved in the project choice.

Cost-benefit analysis of AR-V7 testing in patients (Pts) with metastatic castration resistant prostate cancer (mCRPC) eligible for abiraterone (Abi) or enzalutamide (Enza).

2016 ◽  
Vol 34 (2_suppl) ◽  
pp. 283-283
Author(s):  
Mark Christopher Markowski ◽  
Kevin D. Frick ◽  
James R. Eshleman ◽  
Jun Luo ◽  
Emmanuel S. Antonarakis
Keyword(s):  
Cost Benefit Analysis ◽  
Cost Savings ◽  
Cost Benefit ◽  
Benefit Analysis ◽  
Castration Resistant Prostate Cancer ◽  
The Us ◽  
Effective Option ◽  
Current Price ◽  
Societal Challenge ◽  
The Cost

283 Background: The rising cost of oncology care in the US is an ongoing societal challenge, and identifying biomarkers that inform clinical decisions and reduce the use of ineffective therapies remains elusive. A splice variant of the androgen receptor, AR-V7, was found to confer resistance to Abi and Enza in men with mCRPC, but did not negatively affect responses to taxanes, suggesting that early use of chemotherapy may be a more effective option for AR-V7(+) pts. With the recent development of a CLIA-certified clinical assay for AR-V7 at Johns Hopkins, we hypothesized that AR-V7 testing in mCRPC pts may result in cost savings by avoiding futile treatment with Abi/Enza in men with AR-V7(+) disease. Methods: We calculated the cost savings of performing AR-V7 testing in mCRPC pts prior to starting Abi/Enza (and avoiding these drugs in AR-V7(+) men) versus treating all mCRPC pts with Abi/Enza (without use of the biomarker). We have set the cost of the AR-V7 assay at $1000. The cost of 3 months of Abi/Enza (the minimum time it would take to determine resistance, clinically) was approximated at $20,000. We estimated that 30,000 mCRPC pts per year are eligible for Abi/Enza in the US. Results: In our prior studies, about 30% of mCRPC pts previously treated with Abi/Enza had detectable AR-V7 in CTCs. Assuming an AR-V7 prevalence of 30%, about 9,000 AR-V7(+) mCRPC pts per year would receive ineffective treatment with Abi/Enza, at an estimated cost of $180 Million. The upfront cost of testing all mCRPC pts who are Abi/Enza-eligible for AR-V7 is $30 Million, resulting in a net cost savings of $150 Million. When performing a continuous cost-benefit analysis after assuming other prevalences of AR-V7 (ranging from 4% to 50%) and a range of costs for Abi/Enza ($2000 to $24,000 per 3 months), we determined that AR-V7 testing would result in a cost savings as long as the prevalence of AR-V7 is > 5% (if the cost of 3 months of Abi/Enza remains at $20,000). Conclusions: AR-V7 testing in mCRPC pts (at $1000/test) is cost-beneficial when considering the current price of Abi/Enza, and may reduce the ineffective use of Abi/Enza leading to a net cost savings to the healthcare system.

scholarly journals A Cost-Benefit Analysis of Gown Use in Controlling Vancomycin-ResistantEnterococcusTransmission Is It Worth the Price?

2004 ◽  
Vol 25 (5) ◽  
pp. 418-424 ◽  
Author(s):  
Laura A. Puzniak ◽  
Kathleen N. Gillespie ◽  
Terry Leet ◽  
Marin Kollef ◽  
Linda M. Mundy
Keyword(s):  
Infection Control ◽  
Nosocomial Infections ◽  
Cost Benefit Analysis ◽  
Cost Benefit ◽  
Base Case ◽  
Benefit Analysis ◽  
Net Benefit ◽  
Control Policies ◽  
Services Delivery ◽  
The Cost

AbstractObjective:To determine the net benefit and costs associated with gown use in preventing transmission of van-comycin-resistantEnterococcus(VRE).Design:A cost-benefit analysis measuring the net benefit of gowns was performed. Benefits, defined as averted costs from reduced VRE colonization and infection, were estimated using a matched cohort study. Data sources included a step-down cost allocation system, hospital informatics, and microbiology databases.Setting:The medical intensive care unit (MICU) at Barnes-Jewish Hospital, St. Louis, Missouri.Patients:Patients admitted to the MICU for more than 24 hours from July 1, 1997, to December 31, 1999.Interventions:Alternating periods when all healthcare workers and visitors were required to wear gowns and gloves versus gloves alone on entry to the rooms of patients colonized or infected with VRE.Results:On base-case analysis, 58 VRE cases were averted with gown use during 18 months. The annual net benefit of the gown policy was $419,346 and the cost per case averted of VRE was $1,897. The analysis was most sensitive to the level of VRE transmission.Conclusions:Infection control policies (eg, gown use) initially increase the cost of health services delivery. However, such policies can be cost saving by averting nosocomial infections and the associated costs of treatment. The cost savings to the hospital plus the benefits to patients and their families of avoiding nosocomial infections make effective infection control policies a good investment.

The Cost-Benefit Analysis for the Evaluation of Public Infrastructure Projects - The Case of the Subway of Potenza

2014 ◽  
Vol 1073-1076 ◽  
pp. 1362-1367
Author(s):  
Benedetto Manganelli
Keyword(s):  
Cost Benefit Analysis ◽  
Cost Savings ◽  
Cost Benefit ◽  
Economic Feasibility ◽  
Transport Infrastructure ◽  
Benefit Analysis ◽  
Public Infrastructure ◽  
New Public ◽  
The Cost ◽  
The City

In the present work the economic feasibility of a project of public infrastructure, the expansion of the subway of the city Potenza, is estimated. The assessment has been developed through the application of the Cost-Benefit Analysis. As is known the advantage of this technique is the ability to express in monetary terms the externalities (positive and negative) generated by the project. In this case, the external cost savings related to the improvement of the mobility in the city have been internalized. The research has shown that the valuation of the externalities can be an effective way to manage the planning of new public transport infrastructure.

Persuasion and Economic Efficiency: The Cost-Benefit Analysis of Banning Abortion

1993 ◽  
Vol 9 (2) ◽  
pp. 229-252 ◽  
Author(s):  
Julianne Nelson
Keyword(s):  
Cost Benefit Analysis ◽  
Cost Benefit ◽  
Status Quo ◽  
Benefit Analysis ◽  
Pareto Improvement ◽  
Net Benefit ◽  
Policy Debates ◽  
The Status ◽  
The One ◽  
The Cost

How do economists persuade their readers that one policy is superior to another? A glance at the literature on welfare economics quickly provides the answer to this question: Economists enter policy debates armed with mathematical models, evaluating options on the basis of their consequences. Economists typically classify a policy change as a welfare (or “potential Pareto”) improvement with respect to the status quo if the gain realized by the winners exceeds the harm sustained by the losers. The best policy becomes the one that generates the highest net benefit.

scholarly journals Cost-benefit analysis of flight extended operations (ETOPS) for Garuda Indonesia airways

2018 ◽  
Vol 49 ◽  
pp. 02015
Author(s):  
Ratna Purwaningsih ◽  
Lakshita Pritandari ◽  
Haryo Santoso
Keyword(s):  
Travel Time ◽  
Cost Benefit Analysis ◽  
Cost Benefit ◽  
Cost Structure ◽  
Benefit Analysis ◽  
Fuel Cost ◽  
Net Benefit ◽  
Cost Component ◽  
Direct Flight ◽  
The Cost

Garuda Indonesia reducing the flight cost used flight extended operations (ETOPS). ETOPS can reduce travel time and fuel consumption. The cost-benefit analysis was conducted to compare the flight between NON ETOPS flight and ETOPS flight Cengkareng - Perth - Cengkareng route. Net benefit of ETOPS flight is USD 1.212.863 and NON ETOPS is USD 1.154.894. Cost structure analysis was conducted to identify the percentage of flight cost component. The biggest percentage of cost was direct flight cost. It is equal to 49,53% for route Cengkareng - Perth NON-ETOPS and 47,70% for ETOPS. While for the route Perth Cengkareng NON-ETOPS and ETOPS have the same amount of 46.03%. Based on the results of the cost-benefit analysis, it is evident that the ETOPS flight can reduce the fuel cost, although the flight requires trained pilots. Contribution of the paper is brief describe on the structure of revenue and expenditure items in airways business. The structure is specific, different from other transportation business.

Sign in / Sign up

Export Citation Format

Share Document